Nektar Therapeutics (NASDAQ:NKTR) Stock Has Fallen -19.75% YTD, What Do Analysts Anticipate Next?
In last trading session, Nektar Therapeutics (NASDAQ:NKTR) saw 0.95 million shares changing hands with its beta currently measuring 0.55. Company’s recent per share price level